Analysis of free d-serine in mammals and its biological relevance

• Published in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 879; no. 29; pp. 3169 - 3183
• Main Author: Nishikawa, Toru
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-11-2011
• Subjects: Animals; biosynthesis; blood; Brain; Brain - metabolism; Brain Chemistry; cell death; chromatography; cognition; d-Serine; Glutamate neurotransmission; glutamic acid; Glutamic Acid - metabolism; Humans; mammals; Mental Disorders - metabolism; N-methyl- d-aspartate receptor; neuroglia; neurons; Neuropsychiatric disorders; neurotransmitters; pathophysiology; receptors; Receptors, N-Methyl-D-Aspartate - metabolism; retina; schizophrenia; Serine - analysis; Serine - metabolism; Stereoisomerism; Synapse–glia interaction; tissues; Brain; AMPA; BBB; ALS; l-glu; CNS; SNARE; DAOA; Aβ; DPAG; SRR; PSAT; THF; CBT; SNP; ASCT2; Gly; NMDA; SHMT; PSPH; d-ser; GLYT; Synapse–glia interaction; Glutamate neurotransmission; N-methyl- d-aspartate receptor; SOD1; PTSD; DAO; GRIP; 3-PGDH; Neuropsychiatric disorders; GCS; Dsm-1/PAPST-1; GABA; Asc-1; DA; d-Serine
• ISSN: 1570-0232; 1873-376X
• DOI: 10.1016/j.jchromb.2011.08.030

d-Serine is a unique endogenous substance enriched in the brain at the exceptionally high concentrations as a free
d-amino acid in mammals throughout their life. Peripheral tissues and blood contain low or trace levels of the
d-amino acid. In the nervous systems,
d-serine appears to act as an intrinsic coagonist for the
N-methyl-
d-aspartate type glutamate receptor (NMDA receptor) based upon the following characteristics: (i)
d-serine stereoselectively binds to and stimulates the glycine-regulatory site of the NMDA receptor consisting of GRIN1/GRIN2 subunits more potently than glycine with an affinity and ED50 at high nanomolar ranges, (ii) the selective elimination of
d-serine in brain tissues attenuates the NMDA receptor functions, indicating an indispensable role in physiological activation of the glutamate receptor, and (iii) the distribution of
d-serine is uneven and closely correlated with that of the binding densities of the various NMDA receptor sites, and especially of the GRIN2B subunit in the brain. Moreover,
d-serine exerts substantial influence on the GRIN1/GRIN3-NMDA and δ2 glutamate receptor. In the brain and retina, metabolic processes of
d-serine, such as biosynthesis, extracellular release, uptake, and degradation, are observed and some candidate molecules that mediate these processes have been isolated. The fact that the mode of extracellular release of
d-serine in the brain differs from that of classical neurotransmitters is likely to be related to the detection of
d-serine in both glial cells and neurons, suggesting that
d-serine signals could be required for the glia–synapse interaction. Moreover, the findings from the basic experiments and clinical observations support the views that the signaling system of endogenous free
d-serine plays important roles, at least, through the action on the NMDA receptors in the brain wiring development and the regulation of higher brain functions, including cognitive, emotional and sensorimotor function. Based upon these data, aberrant
d-serine–NMDA receptor interactions have been considered to be involved in the pathophysiology of a variety of neuropsychiatric disorders including schizophrenia and ischemic neuronal cell death. The molecular and cellular mechanisms for regulating the
d-serine signals in the nervous system are, therefore, suitable targets for studies aiming to elucidate the causes of neuropsychiatric disorders and for the development of new treatments for intractable neuropsychiatric symptoms.